Searched for
HERITAGE PHARMA
Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...24 Apr, 2026, 09.03 AM IST- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%The market is again abuzz with the possibility of peace in the Gulf. This has, however, happened in the past. There is, thus, no point in g...06 Apr, 2026, 01.35 PM IST
- Beyond TDP euphoria! Andhra-linked stocks that are worth buying for the long termStocks of companies linked to Andhra Pradesh surge post TDP victory, led by Heritage Foods and Aurobindo Pharma.13 Jun, 2024, 04.01 PM IST
- Stock market update: Nifty Pharma index advances 2.62% in an upbeat marketThe Nifty Pharma index was trading 2.62 per cent up at 19090.75.05 Jun, 2024, 10.09 AM IST
- Stock market update: Nifty Pharma index falls 1.1% in a weak marketThe Nifty Pharma index was trading 1.1 per cent down at 19108.4.30 May, 2024, 10.19 AM IST
- Corporate Radar: LIC Q4 results, JSW Steel's dividend, Tilaknagar's referential issue & moreLIC, Sun Pharma, IRCTC, Jindal Steel & Power, Delhivery, Jubilant FoodWorks and Aurobindo Pharma are among the companies which will announc...30 May, 2022, 08.27 AM IST
- Stock market update: Nifty Pharma index advances 1.13% in an upbeat marketThe Nifty Pharma index was trading 1.13 per cent up at 14128.7.27 Oct, 2021, 10.25 AM IST
- PEs in talks for Emcure stake; promoters eye $2 billion valuationJM Financial is advising the company for the stake sale.12 Feb, 2020, 10.29 AM IST
- Pharma stocks crash after US lawsuit over price manipulationsThe other generic makers named in the suit include Apotex, Teva, Heritage Pharma and Par Pharma.14 May, 2019, 08.46 AM IST
- Indian execs 'named' in US pharma caseThe Indian generic makers named in the lawsuit are Aurobindo, Dr Reddy’s, Emcure, Glenmark, and Zydus.11 Apr, 2019, 10.11 AM IST
- US states sue 5 Indian generic drug makers over price cartelisationThe new lawsuit has also named some individual executives, including Rajiv Malik, president of Mylan, and Satish Mehta, MD of Emcure Pharma.02 Nov, 2017, 09.25 AM IST
- Drug companies can't rely on extreme price hikes in US: Glen SaldanhaBrokerage firms that were bullish on Indian drug makers are also feeling the jitters of the DOJ investigation and the threat of free market...22 Dec, 2016, 10.38 AM IST
- What class action suit against Taro means for Sun PharmaAnalysts were jittered by the DOJ investigation of drug pricing, with some brokerages cutting down the forecast for the Indian pharma secto...21 Dec, 2016, 09.27 AM IST
- Food enrichment for a healthier India20 Dec, 2016, 04.39 PM IST
- US generics probe reveals startling detail of price fixing in Doxycycline and GlyburideA Bloomberg report said two executives of Heritage Pharma – the US arm of Indian drug maker Emcure - are preparing to plead guilty to price...15 Dec, 2016, 09.45 AM IST
- US subsidiary of Sun Pharma gets sub poena from US Justice DepartmentTwo market analysts were of the view that the move may lead to a subdued sentimental outlook in the near term for Sun Pharma.29 May, 2016, 02.39 PM IST
- Emcure Pharmaceuticals acquires Canadian company and its marketing arm MarcanMarcan Pharma has over 60 approved products that are mainly available via McKesson and Kohl & Frisch, among other wholesalers, it claimed.18 Jan, 2016, 05.09 PM IST
Load More
